Cirrhosis is associated with a reduction in muscle mass and exercise capacity. This has an impact on morbidity and mortality. Regular aerobic exercise training is a proven effective therapy to improve exercise capacity in healthy and clinical populations. The effect of this training has not yet been evaluated in the decompensated cirrhosis patient population. The safety of this intervention also requires further study. Using a randomized controlled design, the investigators aim to determine the safety and efficacy of eight weeks of aerobic exercise training on aerobic capacity, functional performance, and muscle mass in decompensated cirrhosis patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
15
Aerobic exercise
No Intervention
University of Alberta, Mazankowski Heart Institute
Edmonton, Alberta, Canada
Change in peak exercise pulmonary oxygen uptake (peak V02)
Time frame: Baseline (day1) and Study End (8 weeks)
Change in muscle mass as measured by thigh ultrasound
Time frame: Baseline (day 1) and Study End (8 weeks)
Change in quality of life-Chronic Liver Disease Questionnaire
Time frame: Baseline (day1) and Study End (8 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.